Sleep, caregiver burden, and life satisfaction in Parkinson's disease caregivers: a multinational investigation.


Journal

Disability and rehabilitation
ISSN: 1464-5165
Titre abrégé: Disabil Rehabil
Pays: England
ID NLM: 9207179

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 12 9 2020
medline: 3 6 2022
entrez: 11 9 2020
Statut: ppublish

Résumé

The primary aim of this study was to examine the pattern of associations among PD patient and caregiver sleep problems, caregiver burden, and caregiver life satisfaction. A secondary aim was to assess whether the pattern of associations differed between Mexican and U.S. caregivers. Analyses were performed on data obtained from 253 caregivers ( The model was generally invariant across U.S. and Mexican caregivers. Three significant indirect effects were found: caregiver sleep problems were negatively associated with life satisfaction via caregiver burden ( PD patient sleep problems were associated with caregiver sleep problems, leading to increased burden in caregivers and poorer life satisfaction. The findings highlight a potential opportunity for empirically supported sleep interventions.Implications for rehabilitationParkinson's disease is a progressive neurological condition that impacts patient and caregiver quality of life.Patient sleep problems contribute to greater caregiver burden, sleep problems, and reduced life satisfaction.The findings suggest patient and caregiver sleep may be a worthwhile target for intervention in order to reduce risk of caregiver burden and improve life satisfaction.

Identifiants

pubmed: 32915084
doi: 10.1080/09638288.2020.1814878
pmc: PMC7947017
mid: NIHMS1646022
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1939-1945

Subventions

Organisme : NIA NIH HHS
ID : K23 AG049955
Pays : United States

Références

J Community Health. 2008 Feb;33(1):40-50
pubmed: 18080207
Parkinsonism Relat Disord. 2013 Nov;19(11):943-8
pubmed: 23831481
Parkinsonism Relat Disord. 2004 Mar;10(3):157-68
pubmed: 15036171
Age Ageing. 2002 Sep;31(5):349-54
pubmed: 12242196
J Sleep Res. 2018 Jun;27(3):e12673
pubmed: 29493044
J Pers Assess. 1985 Feb;49(1):71-5
pubmed: 16367493
Expert Rev Pharmacoecon Outcomes Res. 2012 Apr;12(2):221-30
pubmed: 22458623
Parkinsonism Relat Disord. 2006 Jan;12(1):35-41
pubmed: 16271496
J Cross Cult Gerontol. 1993 Apr;8(2):137-46
pubmed: 24389833
Sleep Med Rev. 2017 Oct;35:33-50
pubmed: 27863901
Int Psychogeriatr. 2019 Jul;31(7):1039-1045
pubmed: 30318024
Psychol Med. 2015 Aug;45(11):2427-36
pubmed: 25804325
Health Psychol Rev. 2014;8(1):95-127
pubmed: 25053010
Age Ageing. 2006 May;35(3):220-8
pubmed: 16638765
J Pain Symptom Manage. 2017 Feb;53(2):272-278
pubmed: 27810571
Rehabil Res Pract. 2014;2014:718527
pubmed: 25298895
Nurs Res. 2013 Jan-Feb;62(1):45-9
pubmed: 23114795
Int J Psychiatry Med. 2019 May;54(3):203-216
pubmed: 30278803
Mov Disord. 2008 Nov 15;23(15):2129-70
pubmed: 19025984
Curr Sleep Med Rep. 2018 Dec;4(4):268-277
pubmed: 31106115
J Cross Cult Gerontol. 1998;13(3):229-40
pubmed: 14617906
J Clin Sleep Med. 2018 Nov 15;14(11):1849-1857
pubmed: 30373688
Sleep Med. 2020 Jul;71:59-65
pubmed: 32502851
Palliat Med. 2011 Mar;25(2):177-82
pubmed: 20952448
Gerontologist. 2002 Dec;42(6):772-80
pubmed: 12451158
Sleep Med Rev. 2017 Feb;31:6-16
pubmed: 26899742
J Rehabil Res Dev. 2006 Jul-Aug;43(4):499-508
pubmed: 17123189
Nat Rev Neurol. 2014 Dec;10(12):683-93
pubmed: 25385339
Neuron. 2003 Sep 11;39(6):889-909
pubmed: 12971891
Ann Intern Med. 2015 Aug 4;163(3):191-204
pubmed: 26054060
Gerontologist. 1986 Jun;26(3):260-6
pubmed: 3721233
Int Psychogeriatr. 2012 Nov;24(11):1827-35
pubmed: 22652066
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Neurosci Biobehav Rev. 2017 Sep;80:586-604
pubmed: 28757454
Disabil Rehabil. 2008;30(8):600-10
pubmed: 17852325
Sleep Med. 2017 Apr;32:246-256
pubmed: 27743803
Neuropsychopharmacology. 2020 Jan;45(1):121-128
pubmed: 31234200
Gerontologist. 2001 Oct;41(5):652-7
pubmed: 11574710
Int Psychogeriatr. 2016 Jul;28(7):1125-32
pubmed: 26817492
NPJ Parkinsons Dis. 2018 Jul 10;4:21
pubmed: 30003140

Auteurs

Elliottnell Perez (E)

Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.

Paul B Perrin (PB)

Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.
Department of Physical Medicine and Rehabilitation, Virginia Commonwealth University, Richmond, VA, USA.

Sarah K Lageman (SK)

Department of Neurology, Virginia Commonwealth University, Richmond, VA, USA.

Teresita Villaseñor (T)

Department of Neurosciences, University of Guadalajara, Guadalajara, Mexico.

Joseph M Dzierzewski (JM)

Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH